Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection	Hemic and Lymphatic Diseases, Infections, Leukemia-Lymphoma, Adult T-Cell, Neoplasms by Histologic Type, Neuroinflammatory Diseases, RNA Virus Infections, T-cell leukemia, central nervous system disorder, central nervous system infectious disorder, deltaretrovirus infections, hematologic disorder, human T-lymphotropic virus 1 infectious disease, immune system disorder, immunoproliferative disorder, inborn error of immunity, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelitis, neoplasm, nervous system disorder, neuritis, neuromuscular disease, peripheral nervous system disorder, spinal cord disorder, tropical spastic paraparesis, uterine carcinosarcoma, viral infectious disease	Recruiting	Phase 2	2026-06-02		NCT07555431

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Carlos Brites	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hospital Universitário Professor Edgard Santos	Salvador	Brazil	2